According to new insights from Oxford Medical Products, tackling obesity effectively requires more than just breakthrough drugs – it demands a broader, more inclusive strategy that leverages innovation and delivers long-term results.
With growing demand for treatments like Ozempic, the challenge now is ensuring patients receive the right support, not just for weeks or months, but for the full year or more that their journey requires.
There is great ambition from government to lead in life sciences and MedTech innovation. Oxford Medical Products call for the ambition of medical innovators to be met with action: support innovation; equip pharmacies and GPs with the tools to better support patients; and ensure every individual has access to the care pathway that works best for them.
Read more from Camilla Easter, Chief Executive, Oxford Medical Products HERE
